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ABSTRACT 
Objective 
To compare beliefs about medicines, as measured by the BMQ-General questionnaire, at two 
time points for the same respondents. 
Methods 
Respondents completed the BMQ-General as part of two separate postal questionnaires, 
administered with an intervening period of almost four years. BMQ-General scores were 
compared for all respondents at the two time points (2002 and 2005). Scores were also 
compared for three mutually exclusive groups based on changes in self-reported health status 
(better, worse or no change) during the intervening period. 
Results 
BMQ-General scores remained stable over time: no statistically significant differences were 
observed in individuals’ scores after almost four years. This finding persisted amongst 
respondents who reported changes in health status during the intervening period.  
Conclusion 
General beliefs about medicines appear to remain stable over time, irrespective of changes in 
health status. Further research should be done to establish whether specific beliefs about 
medicines prescribed for individuals are similarly stable. 
Practice Implications  
Key words 
Adherence is known to be associated with beliefs about medicines. The observed stability in 
such beliefs could have implications for the design of interventions to improve adherence to 
prescribed medication regimes.  
Adherence, Beliefs about medicines questionnaire, Health beliefs 
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TITLE 
Temporal stability of beliefs about medicines: implications for optimising adherence. 
 
1. INTRODUCTION  
1.1 Background 
The Beliefs about Medicines Questionnaire (BMQ) was developed as an aid to understanding 
people’s perceptions about medicines(1), and their adherence (or non-adherence) to 
prescribed medication regimes(2). Its development was one response to mounting evidence 
that many patients do not use their medicines as directed by the prescriber(3). Estimates of the 
extent of non-adherence vary across studies, largely because of differing methods of 
measurement, difficulties in measuring and inconsistency in the definitions used for the term 
‘adherence’(4). However, one source reports that across different definitions and settings, 
around 50% of medicines are not used as intended by the prescriber(5). Non-adherence to 
prescribed medicines can pose a significant threat to the success of medical treatments and 
intended improvements in health outcomes. Adherence to evidence-based curative or 
preventive drug treatments for most medical conditions is likely to affect the success of those 
treatments, since maintaining optimal blood levels is necessary for efficacy.
 
 Poor health 
outcomes following low adherence can in turn impinge on secondary outcomes, such as the 
cost to society of subsequent unresolved and/or worsening illnesses.  
Various reasons for low adherence have been reported, and these can be categorised as non-
intentional and intentional non-adherence. Non-intentional non-adherence is often the result 
of poor memory or understanding(5). The reasons for intentional non-adherence are less 
straightforward and include problems experienced as a direct result of taking medicines (such 
as adverse drug reactions), inability to pay for medicines, disagreement with the need for 
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pharmacological treatment, or other patient-specific issues associated with complex 
behavioural characteristics (6)
 
. Beliefs about medicines are most likely to be associated with 
intentional non-adherence. 
Previously, a number of theories from health psychology such as the Health Belief Model, 
Theory of Planned Behaviour and the Common Sense Self-regulatory Model of Illness, have 
been used to try to explain variation in adherence to medicines(7). The authors of the BMQ, 
however, argued that a separate, specific measure to gauge patients’ beliefs about medicines 
would add to the explanatory power of such models(1). It was proposed that an enhanced 
understanding of people’s beliefs about medicines could inform the development of 
interventions to improve adherence and optimise the benefits users derive from their 
medicines. It is unclear, however, whether these beliefs are stable over time, or whether they 
change depending on concurrent circumstances. 
 
The BMQ comprises two separate scales(1). The BMQ-Specific scale has two sub-scales and 
assesses respondents’ beliefs about prescribed medicines that they are currently using for 
specific conditions, for example, hypertension, diabetes or asthma. Studies using the BMQ-
Specific sub-scales have shown that respondents with stronger beliefs about the necessity of 
their medication and fewer concerns about their medication (as measured by the BMQ) are 
more likely to use their medicines as recommended by the prescriber(2, 8-11).  
 
The BMQ-General scale measures respondents’ attitudes to medicines in general. It has two 
sub-scales, each with four items. The General-overuse sub-scale measures respondents’ 
beliefs about the extent to which medicines are overused or over-prescribed by doctors. The 
General-harm sub-scale assesses beliefs about the harmfulness of medicines. Items are scored 
 6 
using a 5-point Likert scale. Higher scores indicate stronger beliefs about the corresponding 
concepts in each sub-scale, i.e. more negative beliefs about medicines. Scores for each of the 
BMQ–General sub-scales can range from 4 to 20. The BMQ-General scale has been used 
separately to assess attitudes towards medicines among people who do not share a common 
condition or treatment. For example, one study in Sweden suggested that pharmaceutical 
specialists (pharmacists and prescriptionists) had fewer concerns than patients that medicines 
were harmful or overused(12). Horne et al have reported that pharmacy students have a more 
positive attitude towards medicines than students studying other subjects(13), and that beliefs 
about medicines vary between people from different cultural backgrounds(14). A recent 
Swedish study found that adherence was associated with general attitudes to medicines (as 
measured by the BMQ-General scale); people who believed that medicines were harmful 
were less likely to take medicines as intended by the prescriber(15).   
 
1.2 Temporal stability of beliefs about medicines 
Temporal stability is a property of a construct (e.g. beliefs about medicines) which indicates 
whether the construct changes over time, or under different conditions; for example, whether 
beliefs about medicines are stable or change in response to changes in health state. This would 
be important to know because where such beliefs are associated with behaviour (in this 
example, medicine-taking behaviour), and where that behaviour is maladaptive (such as low 
adherence), changing the behaviour using interventions that target beliefs may be harder to 
achieve when those beliefs are very stable. Previous researchers have proposed that health 
beliefs (including some related to medicines use) are formed at an early age and change little 
thereafter(16). This US study compared the health beliefs and behaviours of 270 children, 
allocated to two groups depending on age (‘11years and over’ and ‘under 11 years’). Their 
findings seemed to indicate that “children’s health related beliefs and behaviors are 
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relatively stable” by the time they reach 9-10 years, and that “few changes take place in these 
orientations as the children move into adolescence”. It is unknown however, whether this 
stability persists into adulthood, or whether experiences such as changes in health status, are 
likely to modify health-related beliefs in later life. 
 
1.3 Aim 
 The aim of this paper is to compare the results of two separate applications of the BMQ-
General scale in the same respondents, over a period of almost four years, in order to explore 
the temporal stability of BMQ scores. The hypothesis was that scores for the two BMQ-
General sub-scales would remain stable over time (suggesting stability of people’s general 
beliefs about medicines) and would not alter with changes in health state. 
 
2. METHOD 
The BMQ-General sub-scales were included in a postal questionnaire, mailed in 2002 to 3000 
individuals randomly selected from the Scottish electoral roll as part of a study about non-
prescribed analgesics(17). The wording of the introductory text preceding the BMQ items was 
adapted slightly from the original(1) for this study (Box 1). As well as the BMQ-General, the 
questionnaire collected information about respondents’ characteristics, their lifestyle and 
recent (within the previous two weeks) use of prescribed and non-prescribed medicines. 
Respondents were also asked to rate their general health using a 5-point Likert scale, ranging 
from excellent to poor.  
 
The BMQ-General scale was administered again 44 months later in 2005. It was incorporated 
into a discrete choice experiment (DCE) questionnaire that measured relative preferences for 
different ways of managing flu-like symptoms(18). This questionnaire was mailed to 652 
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respondents to the original survey who had agreed to participate in further research. The 
questionnaire collected similar demographic and lifestyle information as before, and asked 
respondents to again rate their general health using the same question as in 2002. Both 
questionnaires are available on request from the authors. Respondents’ personal 
characteristics were compared with other statistics describing the Scottish population using 
the χ2
 
 test. 
BMQ-General sub-scale scores were calculated for the two time points (2002 and 2005) and 
compared using a paired t-test. This test compares the means of two related samples when the 
difference between the two groups is Normally distributed. Further comparisons were made 
of the scores of individuals for each item of the sub-scales at the two time points using the 
Wilcoxon signed ranks test. This tests for differences between two related samples where the 
variable of interest (in this case, the BMQ item score) is measured on an interval scale.  
 
Respondents were divided into three mutually exclusive groups: those whose self-reported 
health status had improved or deteriorated (by at least one point on the Likert scale), or 
remained the same at the two time points (2002 and 2005). Mean differences in BMQ scores 
at the two time points were compared for the three groups using one-way analysis of variance 
(ANOVA), a test for Normally distributed data when there are more than two groups to 
compare.  
 
3. RESULTS 
In total, 292 subjects were excluded from the 2002 survey because the questionnaire could not 
be delivered (n=257) or the addressee was unable to participate (n=35) because they no longer 
lived in Scotland, were under 18 years of age or were deceased.  Removing these subjects 
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from the denominator, we had an adjusted response rate of 55% (n=1501/2708). In the 2005 
survey, after excluding 70 subjects whose questionnaire could not be delivered and nine who 
were unable to participate because they were not resident in Scotland, were nursing home 
residents, suffered from dementia or were deceased
 
, the adjusted response rate was 57% 
(n=326/573). A total of 321 respondents to the 2005 survey had scores available for 
comparison with General-overuse scores from the 2002 survey, and 320 paired scores were 
available for the General-harm sub-scale. Missing data for the remaining cases meant that 
BMQ scores could not be calculated. The characteristics of respondents with at least one 
available paired BMQ-General score are given in Table 1. Compared to other statistics for 
Scotland, the respondents had a lower proportion of younger people, smokers and drinkers of 
alcohol (p<0.001). 
The BMQ-General sub-scale scores for respondents at each survey and differences between 
the two time points are summarised in Table 2. BMQ scores for both sub-scales and the 
differences between scores over time were Normally distributed. The paired samples t-test 
revealed no significant differences in the mean scores between both time points, for either 
sub-scale (Table 2). Results of the Wilcoxon signed ranks test which compared the scores of 
individuals on each of the eight items in the BMQ-General over time, are shown in Table 3. 
The number of paired observations for each of the eight items varied between 316 and 323 
because of missing data. There were no statistically significant differences for six of the eight 
items in the scale. The difference between scores for ‘Doctors use too many medicines’ was 
of borderline significance (p=0.05).  The difference between scores for ‘Natural remedies are 
safer than medicines’ was strongly statistically significant (p=0.001); there was a tendency to 
agree less with this item in 2005 compared to 2002.  
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Comparison of results for both surveys indicated that the self-reported health of 20.5% 
respondents had deteriorated, 24.0% had improved and 55.5% had remained the same. Data 
was available to compare General-overuse scores for 313 respondents and General-harm 
scores for 312 respondents. The remainder could not be allocated to one of the three groups 
because of missing data on self-reported health in at least one survey. 
 
ANOVA revealed no 
statistically significant differences in mean changes of either General-overuse scores or 
General-harm scores over time between the health status groups. However, at the group level, 
the 'Better' group did show a small but significant decrease in General-overuse score (Table 
4).  
4. DISCUSSION AND CONCLUSION 
4.1 Discussion  
Our findings support the study hypothesis that general beliefs about medicines remain stable 
over time. No statistically significant differences in the BMQ-General scores of respondents 
were observed after an intervening period of almost four years. In addition, when assessed 
separately, there were no statistically significant differences over time for six of the eight 
BMQ-General items, with one of the other items having only borderline statistical 
significance. Further support for the study hypothesis was the observation that, irrespective of 
changes in self-reported health status, general beliefs about medicines did not differ 
significantly over time. At the group level, General-overuse scores for those whose self-
reported health improved over time showed a slight decrease suggesting a more positive 
attitude towards medicines. The clinical significance of this decrease is uncertain but warrants 
further investigation in future studies. The observed stability in general beliefs about 
medicines is consistent with the conclusions reported in a previous study, that health beliefs, 
including some related to use of medicines, are stable from an early age(16). 
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Optimising the way in which people take medicines is important if the benefits are to be 
maximised and adverse effects minimised. There is a substantial literature describing 
interventions that have aimed to improve adherence, but few have proved effective. For 
example, a recent Cochrane review identified 78 trials that tested 93 interventions to change 
adherence to prescribed medication(19).  The authors concluded that even the most effective 
interventions were of limited value in improving adherence.  
 
A number of published studies covering a variety of clinical areas report that adherence to 
medication regimes is associated with beliefs about medicines (1, 20-24)
 
. If, as their findings 
suggest, low adherence is associated with negative beliefs about medicines, one approach to 
improving adherence would be to apply an intervention that could modify those beliefs. A 
possible explanation for the lack of successful interventions noted in the Haynes et al 
Cochrane review could be the failure of those interventions to modify patients’ knowledge of, 
and beliefs about, their illnesses and treatments. This could be because beliefs about 
medicines are particularly stable and resistant to change, or because inappropriate methods 
were used to try to modify those beliefs.  
In this study we observed that general beliefs about medicines remained stable over time. 
According to the Common Sense Self-Regulatory Model, we might expect that, in the face 
of a change in health status, people's beliefs about the health threat together with their coping 
behaviours (for example, adherence to medication) would be reappraised(25). Their attitudes 
to medicines would therefore be expected to change in the light of this experience. For 
example, use of a successful drug therapy (leading to improved health status) might be 
expected to engender more positive beliefs about medicines than an unsuccessful one. The 
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stability of BMQ-General scores over time observed in this study, even in the face of 
changing self-reported health status, suggests that such reappraisal of general beliefs about 
medicines may not occur. However, we do not know if this means that all beliefs about 
medicines are resistant to change. It is possible that beliefs about specific medicines might 
change according to experience while general beliefs remain stable, but our research did not 
measure those specific beliefs. Further work will be necessary to explore this in more depth.  
 
An alternative explanation for the scarcity of effective adherence interventions might be the 
failure of investigators to apply appropriate techniques to target and change beliefs about 
medicines. Interventions have been developed that can modify other psychological constructs 
such as attitudes or intentions, leading to behaviour change and improved patient outcomes. 
Techniques used have included self-monitoring and feedback(26). Given the apparent link 
between beliefs about medicines and adherence, it would seem reasonable to develop 
interventions that modify negative beliefs about treatment. None of the 93 interventions 
reviewed by Haynes et al in their Cochrane review appeared to specifically target beliefs 
about medicines or use this as an outcome in their evaluations. Other published trials may, 
however, provide some evidence that changing beliefs can improve adherence. For example, 
one trial, excluded from the Cochrane review because it did not measure any treatment 
outcomes, described a theory-based intervention involving provision of telephone advice by a 
pharmacist to 255 patients with a variety of chronic conditions(27). Although a higher than 
expected level of drop-outs left this study underpowered, the findings suggested that 
intervention patients had more positive beliefs about their medicines and better adherence 
after four weeks. Future ‘adherence’ interventions should be designed using a theory-based 
approach that identifies which techniques are most likely to modify beliefs about 
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medicines(28). Interventions specifically designed in this way may have a greater chance of 
success(29). 
 
  
The BMQ-General item that showed the greatest change over time in this study was ‘Natural 
remedies are safer than medicines’. Recent increases in the use of ‘natural’ remedies such as 
herbal and homeopathic preparations, and the high profile of such products in the media, 
might suggest that attitudes towards allopathic medicines are more negative now than in the 
past. However, the reverse was found to be the case in our study as indicated by the tendency 
towards less agreement with this item in 2005 compared with 2002. It could be that warnings 
from the scientific community about potential adverse effects of natural remedies, or their 
interaction with prescription drugs, influenced the perceptions of the public during this 
time(30). Further investigation is necessary to explain this finding. 
 
To our knowledge, this is the first time that the BMQ has been administered twice to the same 
respondents after a period of several years. Our participants were self-selected because they 
4.2 Study strengths and limitations 
were volunteers who agreed to take part in further research when responding to our first 
questionnaire. This could have introduced response bias. In addition, there were 
proportionately fewer younger people, smokers and drinkers of alcohol in our study than in 
the Scottish population in general. However, the differences were fairly small and the 
relatively large sample spanned a broad range of other personal characteristics and health 
status, increasing the generalisability of our results. Although some changes were made to the 
wording of the instructions to participants completing the BMQ to suit our original study 
aims, these were very minor and are not expected to have affected the way in which the 
questions were answered.  We do not know whether people’s specific beliefs about prescribed 
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medicines, as measured by the BMQ-Specific scale of the questionnaire, are also stable over 
time. A study measuring BMQ-Specific scores at two time points would be needed to 
investigate this. 
 
4.2 Conclusion  
We have found that general beliefs about medicines appear to remain stable over time, 
irrespective of changes in health status. We do not know, however, if beliefs about medicines 
prescribed for specific conditions will be similarly stable, whether interventions specifically 
designed to influence beliefs about medicines can modify those beliefs and/or adherence, or 
whether such modifications would result in beneficial outcomes. Further research is needed to 
address these issues.  
 
4.3. Practice Implications 
For the reasons discussed above, the observed stability in beliefs about medicines could have 
implications for interventions to improve adherence to prescribed medication regimes. Given 
the association between beliefs about medicines and adherence to medication regimes, it may 
be helpful for practitioners to assess these types of beliefs in patients for whom they prescribe 
medication. Such assessment would provide the opportunity to discuss patients’ beliefs with 
them. However, practitioners should avoid the assumption that such discussions, or changes 
in patients’ health status, will alter their beliefs. This study presents evidence to suggest that 
these beliefs may not be easily changed. Furthermore, at present there appears to be no RCT-
level evidence that coaching interventions or other attempts at persuasion would modify 
beliefs about medicines, as none of the trials in the Cochrane review(19) evaluated the effect 
of interventions on this variable. 
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